The global humanized mouse model market is poised for substantial growth, with projections indicating a rise from USD 101.5 million in 2023 to USD 178.3 million by 2033, growing at a steady CAGR of ...

Scientific Resurrection Even before the dawn of civilization, many species went extinct, usually from a mix of climate warming at the end of the Ice Age, and over-hunting or competition with early ...

A research team from Helmholtz Munich and the Technical University of Munich has developed an advanced delivery system that ...

A research team has developed an advanced delivery system that transports gene-editing tools based on the CRISPR/Cas9 gene-editing system into living cells with significantly greater efficiency than ...

Mitochondrial diseases, arising from mutations in mitochondrial DNA (mtDNA), are a diverse group of disorders that lead to ...

Another company looking to initiate clinical trials with an epigenetic-editor-based treatment for hepatitis is nChroma Bio.

In a landmark study, researchers at the University of Nebraska Medical Center developed a novel mouse model of Alzheimer’s disease that, for the first time, enables the study of how ...

The global humanized liver mice model market is on a strong growth trajectory, fueled by the increasing prevalence of liver ...

New precision genome editing technologies are transforming the therapeutic landscape for patients with certain cancers and ...

Congenital hearing loss refers to impaired auditory function that occurs due to genetic causes. GJB2 is the gene responsible for approximately half of all cases of hereditary hearing loss.

A new CRISPR-based technology, called RIDE, is a leap forward for this trail-blazing technology. With the precision of a scalpel sharp enough to rewrite the very code of life, researchers have used it ...